南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

基于模型分析揭示人类癌症中改变自噬选择性的突变

Model-based analysis uncovers mutations altering autophagy selectivity in human cancer

Han Zhu, Zhang Weizhi, Ning Wanshan, Wang Chenwei, Deng Wankun, Li Zhidan, Shang Zehua, Shen Xiaofei, Liu Xiaohui, Baba Otto, Morita Tsuyoshi, Chen Lu, Xue Yu, Jia Da

Journal:Nature Communications

IF:14.92

DOI:10.1038/s41467-021-23539-5

PMID:34059679

Published:2021-05-31

research field:分子生物学皮肤病学免疫学遗传学

Abstract

Autophagy can selectively target protein aggregates, pathogens, and dysfunctional organelles for the lysosomal degradation. Aberrant regulation of autophagy promotes tumorigenesis, while it is far less clear whether and how tumor-specific alterations result in autophagic aberrance. To form a link between aberrant autophagy selectivity and human cancer, we establish a computational pipeline and prioritize 222 potential LIR (LC3-interacting region) motif-associated mutations (LAMs) in 148 proteins. We validate LAMs in multiple proteins including ATG4B, STBD1, EHMT2 and BRAF that impair their interactions with LC3 and autophagy activities. Using a combination of transcriptomic, metabolomic and additional experimental assays, we show that STBD1, a poorly-characterized protein, inhibits tumor growth via modulating glycogen autophagy, while a patient-derived W203C mutation on LIR abolishes its cancer inhibitory function. This work suggests that altered autophagy selectivity is a frequently-used mechanism by cancer cells to survive during various stresses, and provides a framework to discover additional autophagy-related pathways that influence carcinogenesis.

本文使用的Yeasen产品

购物车
客服
转染试用